December 28, 2022 | Read Online

All eyes on TSLA for a bounce play

Together with

Good day, 360 –

Here are our top 3 trade ideas today – these setups look primed!

And here's your invitation to get laser-focused in 2023 🚀. ONE stock, ONCE daily from one of the best educators & traders out there. Click HERE to see how!

LUCY - Innovative Eyewear rockets over 80% in pre-market on multi-year license agreement with Eddie Bauer

CLNE - Clean Energy Announces Sustainability-Linked Financing with Riverstone Credit Partners to Fund RNG Growth

TSLA - All eyes on TSLA for a bounce play

A Message from RAD AI*

Over $75 billion a year is wasted on ineffective marketing campaigns, as companies lack the capability to authentically connect with diverse audiences.

But with RAD AI – wasting money on marketing just got harder…

By blending the magic of storytelling with the mastery of AI, RAD customers have seen a 4 times increase in content volume for their allocated budget, and experienced a 250% performance increase across every digital marketing channel.

To learn more about how RAD AI rocks these performance metrics, you can watch their short four-minute video HERE.

And if investing in this type of cutting-edge technology interest you, click here to learn more about this unique opportunity!

*This is an issuer-paid advertisement, see disclosure below

LUCY - Innovative Eyewear rockets over 80% in pre-market on multi-year license agreement with Eddie Bauer

Innovative Eyewear (LUCY), developer and retailer of smart eyewear announced this morning that it had licensed the iconic outdoor brand Eddie Bauer® for smart eyewear.

The stock has steadily climbed post the press release this morning up over 80% this am.

Given the stock is down over 70% after trading above $6.50 in its IPO as recently as August 2022, there is big bounce potential here which we're seeing in the pre-market.

The $1.40-$1.50 was an area of prior support back in October and could act as potential support today.

Above it the first target would be the pre-market high at $1.79 then the psychologically important $2 round number. Above that $2.32 was a prior resistance level.

Below $1.40 the next potential support area is $1.25 with $1 below that. LUCY closed yesterday at $0.8274.

CLNE - Clean Energy Announces Sustainability-Linked Financing with Riverstone Credit Partners to Fund RNG Growth

Clean Energy Fuels Corp (CLNE) announced this morning that it entered into a four-year $150 million sustainability-linked senior secured term loan with Riverstone Credit Partners L.P. ("Riverstone Credit Partners"), a dedicated credit investment platform focused on energy, power, decarbonization and infrastructure.

2 weeks ago UBS initiated coverage on the stock with a Buy rating and $12 target, representing over 100% from current levels. CLNE is gapping around 1.5% higher so far in pre-market trade.

$5.22 was an area of prior support in CLNE that will be an important pivot point.

Above it, potential targets to the upside are $5.50, $6 and then $6.50.

Below it, there is a gap to fill at $5.09 with the next potential support area at $4.70-$4.65 and then $4.35.

TSLA - All eyes on TSLA for a bounce play

TSLA continued its freefall yesterday after it was reported that it would extend its light production schedule in Shanghai in January. The momentum to the downside has been severe, with TSLA closing RED 7 days straight. A lot of people have been burned trying to catch this falling knife, however TSLA is in extremely oversold territory and I expect the bounce, if it occurs, to be significant.

There was more capitulation selling this morning as TSLA traded as low as the $105's in early pre-market. The stock has since stabilized and is gapping slightly higher post 7am.

Yesterday's close of $109.10 should be an important pivot point today.

Above it, targets to the upside are $115, $120 and $125 in the very short term (i.e., today).

Below it, potential support is at $105 from the pre-market this morning, then the psychological $100, with $92 the next support below that.

It should be noted $110 was actually a huge support level from September 2020, after which TSLA ran to $150 quite quickly, so that is a MAJOR area of interest today.

Economic Calendar Thursday

Redbook Sales 8:55am ET

Pending Home Sales 10:00am ET

Richmond Fed Mfg Index 10:00am ET

API Crude Oil Data 4:30pm ET

Earnings

After Market:

CALM

GILD JNCE: Gilead to Acquire All Remaining Rights to Potential First-In-Class Immunotherapy GS-1811 from Jounce Therapeutics

TSLA Tesla is no longer one of the 10 biggest companies in the U.S. by market cap after its 11% slide today--Dow Jones Market Data

TSLA Baird Analyst Ben Kallo lowered the firm's price target on Teslas to $252 from $316 and keeps an outperform rating on the shares

TSLA South Korean retail investors have bought a net $2.8 billion worth of Tesla Inc. stock this year amid the electric-vehicle maker's worst slump on record BBG bloomberg

TSLA California has passed a new law going into effect in 2023 that bans Tesla and other automakers from advertising their vehicles as "fully self-driving." insideevs.com

AZN AstraZeneca's Imjudo/Imfinzi combo gets approval in Japan for liver, lung cancers

AZN Japan approves AstraZeneca's blood cancer drug Calquence

CLNE Clean Energy Announces Sustainability-Linked Financing with Riverstone Credit Partners to Fund RNG Growth

BA BOC Aviation Announces Order for 40 Additional Boeing 737-8 Jets

PFE U.S. FDA Accepts for Review the Biologics License Application for Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents

AMC CEO Asks Board to Freeze His Pay—and Wants Other Top Execs to Forgo Raises. AMC Entertainment Holdings Chief Executive Adam Aron said Tuesday he has asked the company's board to "red circle and freeze" his target cash and stock pay for 2023 Barrons

UTRS Minerva Surgical Announces $30 Million Private Placement of Common Stock Led by Accelmed Partners

CANF Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer

NERV: Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia

To Your Success!

62 Calef Hwy #233 Lee, New Hampshire 03861 United States

DISCLAIMER: To more fully understand RagingBull.com, LLC's issuer-paid advertisement disclaimer and disclosure policy located at https://ragingbull.com/paid-advertisement-disclaimer/.

ISSUER-PAID ADVERTISEMENT: This Issuer has paid RagingBull.com, LLC ("Raging Bull") thirty two thousand five hundred dollars to run advertisements enhancing public awareness of the company. Raging Bull is currently invested in this company.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. Raging Bull strongly recommends you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this Advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Investing in the private companies discussed in this Advertisement is highly risky. There is currently no market for trading or liquidating the securities discussed in this Advertisement and there is no guarantee that a market will develop in the future. Readers of this Advertisement bear responsibility for their own investment research and decisions and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money INVESTING OR trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Raging Bull nor any of its owners, employees OR INDEPENDENT CONTRACTORS is CURRENTLY registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements.In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements in addition to any other relief to which it may be entitled.